A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care

Depression Clinical Trial

Official title:

A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00386711
• Other study ID #: NBH038
• Status: Not yet recruiting
• Phase: Phase 1
• First received: October 10, 2006
• Last updated: October 10, 2006
• Start date: October 2006
• Est. completion date: January 2007

Study information

• Verified date: October 2006
• Source: Nanjing Medical University
• Contact: Yong Tang, Doctor
• Phone: 13851603705
• Email: tangyong1967[@]gmail.com
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

improve detection and management of suicide risk among depressed patients in primary care

Description:

After intervention of training on the identification and management of depression and suicide risk in primary health care professionals, the ability of detection and management of suicide risk among depressed patients in primary care is expected to be improved compared to baseline evaluation.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2160
• Est. completion date: January 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• consecutive outpatient

Exclusion Criteria:

• severe physical conditions

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Depression
• Suicide

Intervention

Behavioral:
• training on identification of suicide risk and depression

Locations

Country	Name	City	State
China	Nanjing Brain Hospital	Nanjing	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Kappa of diagnostic consistency
Secondary	ratio of optimal managment